These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. Feng H; Li B; Li Z; Wei Q; Ren L BMC Cancer; 2021 Apr; 21(1):401. PubMed ID: 33849479 [TBL] [Abstract][Full Text] [Related]
7. Serum histamine and acetylcholine variations as new noninvasive biochemical markers in staging of experimental hepatocellular carcinoma. Abdel-Hamid NM; Abdullah AH Clin Exp Med; 2019 Feb; 19(1):115-120. PubMed ID: 30460419 [TBL] [Abstract][Full Text] [Related]
8. Full-length soluble CD147 promotes MMP-2 expression and is a potential serological marker in detection of hepatocellular carcinoma. Wu J; Hao ZW; Zhao YX; Yang XM; Tang H; Zhang X; Song F; Sun XX; Wang B; Nan G; Chen ZN; Bian H J Transl Med; 2014 Jul; 12():190. PubMed ID: 24996644 [TBL] [Abstract][Full Text] [Related]
9. Possible role of selective, irreversible, proteasome inhibitor (carfilzomib) in the treatment of rat hepatocellular carcinoma. Mansour MA; Aljoufi MA; Al-Hosaini K; Al-Rikabi AC; Nagi MN Chem Biol Interact; 2014 May; 215():17-24. PubMed ID: 24632418 [TBL] [Abstract][Full Text] [Related]
10. The expression of tuftelin 1 as a new theranostic marker in early diagnosis and as a therapeutic target in hepatocellular carcinoma. Abdel-Hamid NM; Zakaria SM; Ansary AM; El-Senduny FF; El-Shishtawy MM Cell Biochem Funct; 2023 Oct; 41(7):788-800. PubMed ID: 37470499 [TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective and anti-tumor effects of targeting MMP-9 in hepatocellular carcinoma and its relation to vascular invasion markers. Elewa MA; Al-Gayyar MM; Schaalan MF; Abd El Galil KH; Ebrahim MA; El-Shishtawy MM Clin Exp Metastasis; 2015 Jun; 32(5):479-93. PubMed ID: 25999065 [TBL] [Abstract][Full Text] [Related]
12. The potential chemotherapeutic effect of β-ionone and/or sorafenib against hepatocellular carcinoma via its antioxidant effect, PPAR-γ, FOXO-1, Ki-67, Bax, and Bcl-2 signaling pathways. Abd-Elbaset M; Mansour AM; Ahmed OM; Abo-Youssef AM Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1611-1624. PubMed ID: 32270258 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of squamous cell carcinoma antigen-immunoglobulin M complex (SCCA-IGM) and alpha-L-fucosidase (AFU) as novel diagnostic biomarkers for hepatocellular carcinoma. Mossad NA; Mahmoud EH; Osman EA; Mahmoud SH; Shousha HI Tumour Biol; 2014 Nov; 35(11):11559-64. PubMed ID: 25129443 [TBL] [Abstract][Full Text] [Related]
14. The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission. Anand R; Wai T; Baker MJ; Kladt N; Schauss AC; Rugarli E; Langer T J Cell Biol; 2014 Mar; 204(6):919-29. PubMed ID: 24616225 [TBL] [Abstract][Full Text] [Related]
15. The Role of Dermcidin in the Diagnosis and Staging of Hepatocellular Carcinoma. Qiu F; Qiu F; Liu L; Liu J; Xu J; Huang X Genet Test Mol Biomarkers; 2018 Apr; 22(4):218-223. PubMed ID: 29641283 [TBL] [Abstract][Full Text] [Related]
16. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
17. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma. Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388 [TBL] [Abstract][Full Text] [Related]
18. Circular RNA hsa_circ_0005397 promotes hepatocellular carcinoma progression by regulating the miR-326/PDK2 axis. Gong J; Du C; Sun N; Xiao X; Wu H J Gene Med; 2021 Jun; 23(6):e3332. PubMed ID: 33783904 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Alpha-Fetoprotein, Protein Induced by Vitamin K Absence, Osteopontin, Dickkopf-1 and Its Combinations for Hepatocellular Carcinoma. Jang ES; Jeong SH; Kim JW; Choi YS; Leissner P; Brechot C PLoS One; 2016; 11(3):e0151069. PubMed ID: 26986465 [TBL] [Abstract][Full Text] [Related]
20. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma. Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]